secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001193125-23-145220
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus reduces ATM equity offering capacity from $150M to $63.75M
------------------------------------------------------------------

- Aggregate offering price under ATM with Cowen reduced by $86.25M, from $150M to $63.75M.
- Amendment No. 1 to November 2022 Sales Agreement executed on May 15, 2023.
- Remaining capacity of $63.75M remains available for future at-the-market sales.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000119312523145220/0001193125-23-145220-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000119312523145220/d443156d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-145220

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer